XML 40 R22.htm IDEA: XBRL DOCUMENT v3.22.2
INTANGIBLE ASSETS
12 Months Ended
Mar. 31, 2022
Intangible Assets [Abstract]  
INTANGIBLE ASSETS INTANGIBLE ASSETS 
CapitalizedTechnology,Other 
 (amounts in millions)
 GoodwilldevelopmentCustomersoftwareintangible
(Note 27)
costsrelationshipsLicensesand ERPassetsTotal
Net book value as at March 31, 2020$1,085.3 $249.5 $312.0 $308.7 $78.9 $22.1 $2,056.5 
Additions – internal development — 48.6 — — 6.9 — 55.5 
Additions – acquired separately— — — — — 0.5 0.5 
Additions – business combinations (Note 3)169.0 — 47.9 — 2.9 — 219.8 
Amortization — (44.6)(29.7)(17.6)(14.7)(2.7)(109.3)
Impairment— (41.4)(9.3)— — (1.1)(51.8)
Transfers and others — 5.3 (0.9)(0.9)(1.4)0.4 2.5 
Foreign currency exchange differences (81.1)(1.7)(22.5)(10.8)(1.1)(0.7)(117.9)
Net book value as at March 31, 2021$1,173.2 $215.7 $297.5 $279.4 $71.5 $18.5 $2,055.8 
Additions – internal development — 55.6 — — 35.0 — 90.6 
Additions – business combinations (Note 3)1,316.8 2.2 323.7 — 169.7 — 1,812.4 
Amortization — (32.7)(40.7)(16.0)(18.3)(1.8)(109.5)
Impairment— (4.2)— — — — (4.2)
Cloud computing transition adjustment (Note 5)
— — — (13.4)— (13.4)
Transfers and others — (2.1)(0.1)(0.1)0.4 — (1.9)
Foreign currency exchange differences (25.7)(0.1)(5.4)(0.5)(1.2)(0.6)(33.5)
Net book value as at March 31, 2022$2,464.3 $234.4 $575.0 $262.8 $243.7 $16.1 $3,796.3 
 
    
 CapitalizedTechnology,Other 
GoodwilldevelopmentCustomersoftwareintangible
(Note 27)
costsrelationshipsLicensesand ERP
assets

Total
Cost$1,210.7 $433.6 $482.6 $313.6 $257.8 $52.4 $2,750.7 
Accumulated amortization and impairment(37.5)(217.9)(185.1)(34.2)(186.3)(33.9)(694.9)
Net book value as at March 31, 2021$1,173.2 $215.7 $297.5 $279.4 $71.5 $18.5 $2,055.8 
Cost$2,501.8 $480.9 $794.7 $312.8 $445.4 $51.1 $4,586.7 
Accumulated amortization and impairment(37.5)(246.5)(219.7)(50.0)(201.7)(35.0)(790.4)
Net book value as at March 31, 2022$2,464.3 $234.4 $575.0 $262.8 $243.7 $16.1 $3,796.3 

During the year ended March 31, 2022, amortization of $77.2 million (2021 – $63.8 million) has been recorded in cost of sales, $30.6 million (2021 – $43.6 million) in research and development expenses and $1.7 million (2021 – $1.9 million) in selling, general and administrative expenses.